Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents

Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents

The administration of a third dose of a vaccine against SARS-CoV-2 has increased protection against disease transmission and severity. However, the kinetics of neutralizing antibodies against the virus has been poorly studied in cancer patients under targeted therapies. Baseline characteristics and...

Full description

Bibliographic Details
Main Authors: Flora Zagouri, Alkistis Papatheodoridi, Michalis Liontos, Alexandros Briasoulis, Aimilia D. Sklirou, Efthymia Skafida, Oraianthi Fiste, Christos Markellos, Angeliki Andrikopoulou, Konstantinos Koutsoukos, Maria Kaparelou, Eirini Gkogkou, Ioannis P. Trougakos, Meletios-Athanasios Dimopoulos, Evangelos Terpos
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
cancer
ARTA
CDK4/6 inhibitors
PARP inhibitors
Online Access:https://www.mdpi.com/2076-393X/10/9/1474

Internet

https://www.mdpi.com/2076-393X/10/9/1474

Similar Items